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SUMMARY 
Phthalates are chemicals used as plasticizers and can be found in a number of different 
consumer products. Phthalates may leak from these products into the environment, and hereby 
humans and animals may be exposed to phthalates through oral intake, dermal exposure and 
inhalation. Experimental studies on primarily rodents have shown that phthalate exposure 
causes toxic effects on the reproductive system, such as effects on the levels of testosterone, 
progesterone and estradiol, the weight and descent of testes, the onset of puberty and 
maintenance of pregnancy. The purpose of this study was to quantify the concentrations of 
phthalate metabolites in urine samples from healthy pet dogs and to investigate relationships 
between the concentrations and the home environment of the dogs using a questionnaire filled 
out by the dogs’ owners. Sixteen dogs were included in the study, with matched groups of 
which eight dogs lived in homes with plastic flooring and eight dogs lived in homes without 
plastic flooring. Urine samples were collected and analysed for ten different phthalate 
metabolites originating from the phthalates diethyl phthalate (DEP), dibutyl phthalate (DBP), 
butylbenzyl phthalate (BBzP), di(2-ethylhexyl) phthalate (DEHP) and diisononyl phthalate 
(DiNP). The results showed that all dogs participating in the study had identifiable levels of 
each of the different metabolites in their urine. The dogs living in homes with plastic flooring 
had higher levels of phthalate metabolites in their urine compared to the dogs living in homes 
without plastic flooring. This difference was statistically significant for MBzP, the metabolite 
of BBzP, and for MEHP, MHEHP, MOEHP and MCEPP, metabolites of DEHP. Plastic toys 
were also identified as a possible risk factor for higher phthalate metabolite concentrations in 
urine. The results of this study show that dogs are exposed to and absorb phthalates from the 
environment, and that dogs living in homes with plastic flooring appear to be exposed to and 
absorb a greater amount of phthalates than dogs living in homes with non-plastic flooring.  
 
SAMMANFATTNING 
Ftalater är en grupp kemikalier som används som mjukgörare av plaster. Ftalater förekommer 
i ett stort antal konsumentprodukter från vilka de kan läcka ut i miljön. Människor och djur 
riskerar därmed att exponeras för ftalater genom oralt intag, genom huden samt via inhalation. 
Ftalater har i studier på framför allt gnagare visats orsaka toxiska effekter på 
reproduktionssystemet, till exempel kan de påverka nivåerna av könshormoner, testiklarnas 
utveckling och nedvandring, tidpunkten för könsmognad och förekomsten av aborter. Syftet 
med den här studien var att kvantifiera halterna av ftalatmetaboliter i urinen hos friska 
sällskapshundar, samt att undersöka om det finns ett samband mellan halterna och hundarnas 
hemmiljö med hjälp av en enkät ifylld av djurägarna. Sexton hundar deltog i studien, med 
matchade grupper bestående av åtta hundar som bodde i hem med plastgolv och åtta hundar i 
hem som saknade plastgolv. Urinprover samlades in och analyserades för tio olika 
ftalatmetaboliter till ftalaterna dietylftalat (DEP), dibutylftalat (DBP), benzylbutylftalat 
(BBzP), di(2-etylhexyl)ftalat (DEHP) och diisononylftalat (DiNP). Resultaten visade att 
samtliga hundar i studien hade mätbara nivåer av samtliga metaboliter i sin urin. De hundar 
som bodde i hem med plastgolv hade högre nivåer av ftalatmetaboliter jämfört med de hundar 
som bodde i hem utan plastgolv. Skillnaden mellan grupperna var statistiskt signifikant för 
MBzP, metabolit till BBzP, och för MEHP, MHEHP, MOEHP och MCEPP, metaboliter till 
DEHP. Plastleksaker identifierades också som en möjlig riskfaktor för att ha högre 
koncentrationer av ftalatmetaboliter. Resultatet av den här studien visar att hundar exponeras 
för och absorberar ftalater från miljön. Dessutom indikerar det att hundar som bor i en miljö 
med plastgolv exponeras för och absorberar en större mängd ftalater jämfört med hundar som 
bor i en miljö som saknar plastgolv.  
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INTRODUCTION 
Phthalates are defined as a group of chemicals with a similar chemical structure (Committee 
on the Health Risks of Phthalates, 2008). They are mainly used as plasticizers to give 
flexibility to materials such as polyvinyl chloride and other polymers (Schettler, 2006).  As a 
consequence, they can be found in a large number of consumer products.   
 
Phthalates, when used as plasticizers, are not chemically bound to their polymer structure, 
which means that they leak out into the environment (KemI, 2014; Heudorf et al., 2007). This 
means that they can, for example, be found in indoor air, household dust and in contaminated 
products such as food products (Heudorf et al., 2007). Some phthalates are considered to be a 
part of the cocktail of endocrine-disrupting chemicals in our environment (Diamanti-
Kandarakis et al., 2009; Wooten & Smith, 2013), and the phthalate chemicals have in many 
studies been associated with toxic effects on the development of the reproductive system in 
laboratory animals, primarily in rodents (Committee on the Health Risks of Phthalates, 2008; 
KemI, 2014). 
 
Since phthalates may affect fertility and reproductive development it is of interest to 
investigate to what degree dogs are exposed to these chemicals. Both to identify if there is a 
risk for pet morbidity, but also to evaluate if data from dogs can be used as an indicator for 
human health risks, seeing as dogs share the same home environment as their human owners.  
 
The purpose of this study is to quantify the concentrations of phthalate metabolites in urine 
from healthy pet dogs and to investigate relationships between the concentrations and the 
home environment of the dogs. This study compares a group of dogs living in homes with 
plastic flooring to a group of dogs living in homes without plastic flooring. The hypothesis is 
that dogs living in homes with plastic flooring are exposed to a higher amount of phthalates, 
and should therefore have a higher amount of phthalate metabolites in their urine. This would 
indicate that dogs, in similarity to humans, are exposed to and absorb phthalates from the 
environment.  
 
LITERATURE REVIEW 
Phthalates 
Phthalates are a group of chemicals with a similar chemical structure (Committee on the 
Health Risks of Phthalates, 2008).  The base structure of phthalates is built up of diesters of 
benzenedicarbxylic acid. The length and structure of the ester side chains varies, thereby 
giving each phthalate its own characteristics (Committee on the Health Risks of Phthalates, 
2008). In Sweden and Europe the most commonly used phthalates are DIDP (diisodecyl 
phthalate), DPHP (di(2-propyl heptyl) phthalate), DEHP (di(2-ethylhexyl) phthalate)  and 
DiNP (diisononyl phthalate)(KemI, 2014).  
 
Phthalates are predominately used as plasticizers in order to give flexibility to materials such 
as polyvinyl chloride and other polymers (Schettler, 2006).  Phthalates are used in a large 
number of consumer products, for example pharmaceuticals and medical devices, insecticides, 
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cosmetics, food packaging, personal-care products, toys, building and cleaning materials and 
household furnishings (Schettler, 2006). A survey conducted by the Swedish Chemicals 
Agency found that on the Swedish market, phthalates are primarily found in PVC (polyvinyl 
chloride) products (KemI, 2014). Other areas of use are rubber products and chemical 
products such as glue, paint and glazing agents (KemI, 2014).  
 
Exposure 
Phthalates are not chemically bound to their polymer structure (KemI, 2014; Heudorf et al., 
2007). This allows them to leach, migrate or evaporate into the environment, causing 
phthalates to be found in indoor air and atmosphere, foodstuff and other materials (Heudorf et 
al., 2007). Human exposure is mainly through direct contact and use of products containing 
phthalates, or by phthalates leaking into other products or contaminating the environment 
(Schettler, 2006). Humans are exposed to phthalates by inhalation, ingestion and dermal 
exposure throughout their whole lifetime, even during intrauterine development (Heudorf et 
al., 2007). A study of German children from 3-14 years of age showed that phthalate urine 
metabolite concentrations decreased with increasing age, and that all children had three to five 
times higher concentrations compared to levels found in adults (Becker et al., 2009). The 
relatively higher exposure for young children could be due to behaviour such as mouthing of 
toys or other PVC products, or through contact with dust when playing on the floor (Becker et 
al., 2004; Wittassek et al., 2007; Sathyanarayana, 2008).  
 
As companion animals, dogs share the same living environment as their owners. This means 
that they most likely are exposed to phthalates from the environment in a similar way to 
humans, and that they too may risk long-term exposure to phthalates (Pathirana et al., 2011). 
Since dogs spend a lot of time on the floor, it is possible that the exposure for dogs may be 
even greater than for their adult owners, following that both the floor itself as well as the 
indoor dust may contain phthalates. 
 
Phthalates such as DiNP and DEHP have been found in children’s toys made out of PVC 
plastics (Stringer et al., 2000). The phthalates DEP (diethyl phthalate) and BBzP (butylbenzyl 
phthalate) could also be found in children’s toys but in smaller amounts.  Since phthalates are 
present in children’s toys, it is possible that they also exist in toys or training equipment used 
for dogs. Wooten & Smith (2013) confirmed that canine toys do contain and leak phthalates 
(DEHP, BBzP, DEP, DBP) into saliva. The study showed that behaviour such as chewing 
(through a simulation) increases the amount of phthalates leaking out. Phthalates (DEHP, 
DiBP) have also been identified in dog toys available on the Swedish market (Nohrborg, 
2015). Conclusively, this means that dog toys are a possible source of phthalate exposure for 
dogs.  
 
Legislation 
Because of the toxic properties of phthalates, their use is regulated. Since February 2015, the 
phthalates DBP (dibutyl phthalate), DEHP, BBzP and DiBP (diisobutyl phthalate) are 
included on the Authorisation List in Annex XIV, in Regulation (EC) No 1907/2006 of the 
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European Parliament and of the Council of 18 December 2006 concerning the Registration, 
Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European 
Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) 
No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 
76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 
2000/21/EC1. Following this, the use of these four phthalates is inhibited, unless a special 
permission has been received. There are further specific restrictions for the use of DEHP, 
DBP and BBzP, DiNP, DIDP (diisodecyl phthalate) and DNOP (di-n-octyl phthalate) in 
children’s toys and childcare products described in Regulation (EC) No 1907/2006, Annex 
XVII.  
 
However, there are exceptions from the Authorisation List for use in packaging of medical 
products and the legislation does not include products imported into the European Union. This 
means that products containing these phthalates will still exist inside the European Union, and 
that exposure to phthalates will continue to be a relevant issue.  
 
Metabolism 
To this date there are few available studies carried out on the metabolism and 
pharmacokinetics of phthalates in dogs. However, Kao et al. (2012) have studied the 
metabolism and pharmacokinetics of DEP and its metabolite MEP in juvenile dogs. They 
found that following either intravenous or oral administration of MEP, 91 % of the 
administered dose was excreted in urine over 24 hours, and 92 % over 72 hours. Similar 
results were found after intravenous administration of DEP where 96 % of the dose was 
excreted in urine within 72 hours, and 90 % of the dose was excreted in urine following oral 
administration. Only 3 % of the dose of both MEP and DEP was excreted in faeces. In other 
words, according to this study, DEP seems to mainly be excreted in urine in dogs.  
 
The absorption and metabolism of the phthalates was rapid in the study by Kao et al. (2012). 
The elimination half-life was estimated to 1 hour. 24 hours after intravenous administration, 
the concentrations of MEP and DEP in plasma were undetectable. The study also showed that 
DEP was rapidly and almost completely metabolised to MEP. 5 minutes after intravenous 
administration of DEP, MEP was the predominant metabolite in plasma. The authors discuss 
that this rapid pace suggests that the metabolism of DEP to MEP in dogs is mostly taking 
place in the blood and liver (Kao et al., 2012).  
 
In an older study by Ikeda et al. (1980), beagle dogs were treated with radioactive DEHP 
through oral administration. 67 % of the dose was excreted in urine and faeces during the first 
24 hours, and excretion was completed in 4 days. In this study faecal excretion was 
predominant in dogs. The elimination half-life was rapid also in this study, and was estimated 
to 1.4 hours.   
 
                                                 
1 OJ L 396, 30.12.2006, p. 1–849, Celex 32006R1907  
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Taken together, these studies indicate that the elimination half-life and excretion of the 
phthalates DEP and DEHP are rapid. However the studies vary by showing that DEP is 
mainly excreted in urine (Kao et al., 2012) while for DEHP faecal excretion was predominant 
(Ikeda et al., 1980). 
 
Toxic effects 
Phthalates have been shown to exert toxic effects on the reproductive system through their 
anti-androgenic properties (Gray et al., 2000; Parks et al., 2000).  The reproductive toxicity of 
phthalates is most pronounced during the early development of the reproductive system 
(Akingbemi et al., 2001). The phthalates DEHP, DBP, BBzP and DiNP all alter sexual 
differentiation in male rats (Gray et al., 2000; Parks et al., 2000). Since phthalates have 
different structures and properties, the degree of toxicity varies. For example, the phthalate 
DiNP is described as 10-20 times less potent than BBzP or DEHP, however still displaying 
anti-androgenic activity (Gray et al., 2000). In addition to their anti-androgenic activity, 
phthalates also target the ovary, affecting the processes of folliculogenesis and 
steroidogenesis in females (Hannon & Flaws, 2015). Because these processes are well 
conserved in mammalian species, results from studies performed on rodents are considered to 
be of importance to other species as well (Parks et al., 2000).   
 
Effects on the male reproductive system 
DEHP crosses the placental barrier in rats (Stroheker et al., 2006) and may therefore affect 
foetuses in utero. The placental barrier does decrease the foetal exposure significantly, but 
does not prevent it completely. Therefore the effect of phthalates on foetuses is of interest and 
has been studied.  
 
Gray et al. (2000) showed that phthalates DEHP, BBzP and DiNP after perinatal (in utero and 
neonatal) exposure all alter the sexual differentiation of male rats through their anti-
androgenic effect. The phthalates caused reduced testosterone levels which in turn lead to 
reproductive malformations, reduced testis weight, shortened anogenital distance, retained 
nipples and undescended testes. Parks et al. (2000) similarly to Gray et al. (2000) demonstrate 
that the phthalate DEHP inhibits testicular testosterone production in male rats after exposure 
during sexual differentiation (in utero and neonatal exposure). Male rats displayed reduced 
testosterone levels, reduced testicular weight, reduced anogenital distance as well as 
histopathological effects (Leydig cell hyperplasia) on the testes.  
 
DEHP may also antagonise the development of accessory sex organs in rats of twenty days of 
age. DEHP has been shown to cause a decrease in the relative weights of the prostate, the 
bulbocavernosus and levator ani muscles and seminal vesicles in male rats (Stroheker et al., 
2005). This is also explained by the anti-androgenic effect of DEHP.   
 
The anti-androgenic effect of phthalates does not seem to result from an antagonistic effect on 
the androgen receptors (AR). Instead, the anti-androgen mechanism appears to be “AR-
independent” (Parks et al., 2000). The phthalates appear to target the testes and inhibit the 
production of testosterone and insulin-like 3 (insl3) (Parks et al., 2000; Wilson et al., 2004), 
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proposedly though inhibiting fetal Leydig cell maturation so that the production of 
testosterone and insl3 mRNA is reduced (Wilson et al., 2004). 
 
The anogenital distance, as mentioned above, is used as a measure of demasculinisation of 
rats exposed to anti-androgenic chemicals (Borch et al., 2006). In utero exposure to DiBP, 
which has similar properties to DBP, showed that DiBP has similar anti-androgenic effects as 
DBP and DEHP in rats, including reduced anogenital distance, reduced testosterone 
production and histopathology of the testes including Leydig cell hyperplasia (Borch et al., 
2006).  
 
The majority of studies on toxic effects of phthalates are carried out on rats, but there is some 
research performed on other species. Higuchi et al. (2003) studied the effects of exposure of 
DBP on male rabbits, both in utero, and before and after puberty. In the group of rabbits 
exposed in utero, there was a reduction in the number of ejaculated sperm, the weight of the 
testicles as well as weight of accessory sex glands. Serum testosterone levels were also lower 
in both the in utero group and the adolescent group, and there was an increased amount of 
abnormal sperm. A few cases of cryptorchidism were also seen, both in the in utero group and 
the adolescent group. The authors conclude that DBP induces lesions in the reproductive 
system of rabbits, the most sensitive stage being the intrauterine period. 
 
Ljungvall et al. (2005) studied the effects of repeated intramuscular administration (twice a 
week for five weeks) of low dose DEHP to prepubertal male pigs. Two weeks after exposure, 
there were no differences in testosterone levels compared to the control group. However, at 
7.5 months of age (4.5 months after the last exposure) the testosterone concentrations were 
higher in the group of pigs previously exposed to DEHP, compared to the control group. In 
other words, the authors found no immediate effects of DEHP on testosterone levels, but 
delayed effects of DEHP were shown. An increase in the number of testosterone-producing 
cells was also seen at 7.5 months of age (Ljungvall et al., 2005). In a different study on the 
immediate and post-pubertal effects of oral DEHP exposure to piglets, DEHP caused 
precocious maturity of the bulbourethral glands (Ljungvall et al., 2008). These two studies 
combined demonstrate that prepubertal exposure to DEHP may cause delayed effects on the 
reproductive system in male pigs.  
 
A study on mice looked at the consequences of oral administration of DBP to male mice from 
four to fourteen days of age (Moody et al., 2013). The study showed that DBP had effects on 
testis growth, caused delayed spermatogenesis, lowered serum testosterone and testicular 
androgen activity as well as a reduced anogenital distance. Conclusively, DBP has anti-
androgenic activity in the mouse, and the neonatal-prepubertal testicles in mice are vulnerable 
to DBP.  
 
Not many studies are performed on the effects of phthalates on dogs. Pathirana et al. (2011) 
carried out an in vitro study on testicular cells from dogs. They concluded that certain 
phthalate esters (MBP, MEHP) had effects on the secretion of testosterone in testicular 
interstitial cells from dogs. The phthalates also had effect on the secretion of insulin-like 
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peptide 3 (INSL3). hCG-induced testosterone and INSL3-secretion were inhibited by both 
MBP and MEHP, however the basal testosterone release was increased by MEHP. Because 
pre-pubertal dogs have low LH-levels, the authors discuss that you might anticipate an 
increase in testosterone concentrations for these individuals and that this could possibly lead 
to hastened puberty. In sexually mature dogs where LH-levels are higher, the authors discuss 
that the hCG-mediated effect on testosterone might be of greater importance.  
 
To conclude, phthalates have been shown to affect the male reproductive system in different 
ways, including effects on testosterone levels, the weight of testes and accessory sex glands, 
the anogenital distance, formation of female-like nipples and the descent of testes (Gray et al., 
2000; Parks et al., 2000; Borch et al., 2006; Stroheker et al., 2005; Higuchi et al., 2003; 
Moody et al., 2013; Pathirana et al., 2011).  
 
Effects on the female reproductive system 
In addition to their effects on the male reproductive system, phthalates have been shown to 
target the ovaries, affecting the folliculogenesis and steroidogenesis, which can lead to effects 
on the female reproductive health (Hannon & Flaws, 2015). For example, MEHP (the active 
metabolite of DEHP) affects granulosa cell estradiol production in the ovaries and 
significantly decreases estradiol production in rats, as shown in an in vitro study by 
Lovekamp & Davis (2001). The same study also suggests that this is due to MEHP down-
regulating the levels of aromatase transcript. Aromatase is the rate-limiting enzyme for 
production of estradiol.  
 
DEHP and its metabolites may also affect oocytes in different manners. Exposure to MEHP 
for 24 hours has been shown to significantly decrease the number of vital oocytes in female 
mice using an in vitro system (Bonilla & Mazo, 2010). DEHP also caused modifications in 
the DNA methylation in fetal mouse oocytes that were shown to be heritable (Li et al., 2014). 
 
In utero exposure to MEHP has been shown to cause reproductive effects in mice (Moyer & 
Hixon, 2012). Female mice exposed to MEHP in utero displayed for example delayed estrous 
onset, prolonged estrous, a decrease in the overall reproductive lifespan, altered estrous 
cyclicity and mammary gland hyperplasia.  As for hormone levels, MEHP exposure caused 
increased serum estradiol and FSH levels in these mice when they reached adulthood. 
Maternal body weight or pup growth was however not affected by this exposure (Moyer & 
Hixon, 2012). A different study on exposure to DEHP via inhalation to prepubertal rats also 
showed effects on the estrous cycle and hormone levels (Ma et al., 2006). Ma et al. (2006) 
showed that female rats exposed to DEHP in the prepubertal period displayed an earlier onset 
of the first estrous cycle, irregular estrous cycles and an increase in serum estradiol-, LH- and 
cholesterol levels. Yet another study on DEHP showed that oral exposure to pre-pubertal 
female rats caused reduced serum progesterone and estradiol levels (Svechnikova et al., 
2007).  
 
Ema et al. (2000) showed that DBP caused a significant increase in the incidence of early 
embryonic loss in pregnant rats, which may be mediated by DBP impairment of uterine 
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function, causing an adverse effect on uterine decidualization. Similar studies revealed similar 
effects of MBP (Ema et al., 2001) and BBzP (Ema et al., 1998); MBP and BBzP both caused 
early (pre- and post-implantation) embryonic loss in rats, mediated at least in part by 
suppressed uterine decidualization. Ema et al. (2000) also conclude that there is an indication 
of DBP being more harmful on embryos during the early post-implantation period compared 
to pre-implantation.  
 
Gray et al. (2006) studied the effects of chronic DBP exposure to female rats, and found that 
oral administration of DBP from weaning, through puberty, mating and pregnancy disrupts 
pregnancy maintenance and induces infertility. Mid-pregnancy abortions were induced and 
the percentage of females delivering live pups was reduced. DBP treatment caused a 
significant decrease in ovarian hormone production and reduced serum progesterone levels.  
The authors speculate that the failure to maintain pregnancy could be due to insufficient 
ovarian progesterone levels, following the effects of DBP. In the study by Ema et al. (1998) a 
similar trend toward decreased serum progesterone levels was seen in rats after exposure to 
BBzP.  
 
In summary, several different phthalates have been associated with toxic effects on the female 
reproductive system, including effects on the levels of progesterone and estradiol, the onset of 
puberty and the estrous cycle, as well as the maintenance of pregnancy (Ema et al., 2000; 
Ema et al., 2001; Ema et al., 1998; Gray et al., 2006; Lovekamp & Davis, 2001; Moyer & 
Hixon, 2012; Ma et al., 2006; Svechnikova et al., 2007).  
 
MATERIAL AND METHODS 
Selection of Dogs 
Sixteen clinically healthy dogs living in Uppsala, Sweden were selected to participate in the 
study. The dogs participating in the study were found by emailing out to veterinary students at 
the Swedish University of Agricultural Sciences. Eight of these dogs lived in homes with over 
50 % plastic flooring, while the other eight dogs lived in homes without plastic flooring. The 
material of the flooring was confirmed through contact with respective landlords in order to 
avoid confusing plastic flooring (PVC) with similar materials such as linoleum. Each group 
consisted of four males and four females, aiming to select dogs of medium size and of 
relatively similar weights, approximately 15-25 kg, to achieve a matching between the two 
groups.  
 
Collection of Samples 
One urine sample of at least 4 ml was collected together with the owner by midstream voided 
catch at one point of time from each dog. The equipment used to collect the sample consisted 
of metal and plastic which was free from phthalates. The dogs had stayed in their home 
environment before the sample was collected, and had not been taken out for a walk for at 
least two hours.  
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The dog owners filled in a questionnaire to provide more information about their dogs’ home 
environment. The owners were asked about the flooring in their homes, material of food 
bowls and toys, how often their home was vacuumed and if their dog had a history of disease 
in the reproductive system. The owners also signed an approval for their dog to participate in 
the study.  
 
After each urine sample was collected, it was immediately put in a cooler and transported to a 
freezer. The urine samples were then stored in a freezer at -20 C until all samples had been 
collected. When all samples had been collected they were sent for analysis to a laboratory at 
the section for Occupational and Environmental Medicine, Department of Laboratory 
Medicine, Faculty of Medicine, Lund University, Sweden.  
 
Analysis 
Each sample was analysed for ten urinary phthalate metabolites originating from five different 
phthalates. The metabolites and their parent compounds are included in Table 1. The 
phthalate metabolites in urine were analysed using liquid chromatography tandem mass 
spectrometry. A detailed description of this technique can be found in Bornehag et al. (2015).  
Table 1. The phthalate metabolites included in the analysis and their parent compounds 
Parent compound Metabolite 
Acronym Diester name Acronym  Monoester name 
DEP  Diethyl phthalate  MEP Mono-ethyl phthalate 
DBP Dibutyl phthalate  MnBP Mono-n-butyl phthalate 
BBzP Butylbenzyl phthalate  MBzP Mono-benzyl phthalate 
DEHP Di(2-ethylhexyl) phthalate  MEHP Mono-(2-ethylhexyl) phthalate 
  MHEHP Mono-(2-ethyl-5-hydroxylhexyl) 
phthalate 
  MOEHP Mono-(2-ethyl-5-oxohexyl) phthalate 
  MCEPP Mono-(2-ethyl-5-carboxypentyl) 
phthalate 
DiNP Diisononyl phthalate  MHiNP Mono-(4-methyl-7-hydroxyloctyl) 
phthalate 
  MOiNP Mono-(4-methyl-7-oxo octyl) phthalate 
  MCiOP Mono-(4-methyl-7-carboxyheptyl) 
phthalate 
 
The metabolite concentrations were adjusted to urine density using the formula below (as 
described in Carnerup et al. (2006)):  
 
 
C(c o r r)
C(o b s) (1.0 3 21)
p1  
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C(corr) is the metabolite concentration corrected for urine density, C(obs) is the observed 
metabolite concentration and p is the specific urine density of the sample. 1.032 is the mean 
urine density of the samples in this study. 
 
The data was then analysed statistically. A normal distribution could not be assumed due to 
the limited sample size and therefore the non-parametric (NPAR1WAY) procedure of SAS 
(SAS Institute Inc., Cary, NC, USA, version 9.02.01) was used to perform one-sided 
Wilcoxon two-sample exact tests. Homogeneity of variances was confirmed by Levene’s test. 
Differences in metabolite concentrations corrected for urine density were tested between type 
of flooring (plastic n=7, or non-plastic flooring n=8), toys (plastic n=6, or non-plastic toys 
n=9) and sex (male n=7, or female n=8). Due to the small sample size for the other 
characteristics of the dogs’ home environment (Table 2), no statistical calculations were 
performed on these variables. 
 
RESULTS 
Dog Characteristics 
Both the plastic and the non-plastic flooring group consisted of 4 female and 4 male dogs 
after purposely selecting this to achieve an even distribution of sexes. One male dog from the 
group with plastic flooring had a urine density that could not be quantified, and it was 
therefore excluded from all calculations carried out on the corrected phthalate metabolite 
concentrations. For these calculations the group with plastic flooring therefore consisted of 4 
female and 3 male dogs.  
 
The aim was to select dogs of similar sizes (around 15-25 kg). The weight of the dogs 
participating in the study ended up ranging from 13-32 kg, with a mean weight of 23.2 kg. 
Age varied from 1 to 13 years, with a mean of 5.4 years. Only one of the dogs had a history of 
disease in the reproductive organs (prostatitis).  
 
There were no differences in body weight or age (p>0.05) between the seven dogs in the 
group with plastic flooring, and the eight dogs in the group with non-plastic flooring. 
Similarly, there were no differences in body weight or age between dogs using plastic toys 
and dogs not using plastic toys. 
 
The owners were asked about their dogs’ home environment (Table 2) to identify other risk 
factors for increased phthalate metabolite concentrations. In the group with plastic flooring, 
5/7 dogs had 100% plastic flooring, 1/7 had 75-100% plastic flooring and 1/7 had 50-75% 
plastic flooring in their homes. The homes of the dogs with plastic flooring were all owned by 
the same landlord (Foundation of Ultuna Student Housing, Uppsala, Sweden), however the 
age of the buildings as well as the type and brand of flooring varied. 
  
Table 2. Characteristics of the study population (n=15) 
Characteristic Group with plastic Group with non-
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flooring, n = 7a plastic flooring, n = 
8 
Type of flooring   
     Plastic 7 0 
     Linoleum 0 4 
     Wood 0 4 
     Other 0 0 
Does the dog have plastic toys?   
     Yes 4 2 
Does the dog have a plastic food 
bowl? 
  
     Yes 1 1 
Frequency of vacuuming the home?   
     1-2 times per month 3 1 
     Once a week 4 4 
     Several times per week 0 3 
aThe dog with immeasurable urine density is not included in this table. 
 
Metabolite Concentrations 
Urine from each of the sixteen dogs was analysed for the ten phthalate metabolites included in 
Table 1. All dogs had measurable levels of each metabolite in their urine. The mean, median 
and range of metabolite concentrations, before correction for urine density, can be found in 
Table 3. The metabolite concentrations after correction for urine density are found in Table 4. 
Sex did not have any influence on the corrected urine concentrations of phthalate metabolites 
(p>0.05). 
 
Table 3. Phthalate metabolite concentrations before correction for urine density, values in ng/ml  
 All dogs (n=16) 
Mean ± standard  
deviation 
Median Range 
MEP 22.6 ± 20.5 14.8 4.5-67.3 
MnBP 60.1 ± 47.3 40.9 7.1-160 
MBzP 75.6 ± 154 14.3 2.7-586 
MEHP 18.4 ± 22.4 8.6 1.3-81.6 
MHEHP 71.7 ± 79.8 27.2 6.9-241 
MOEHP 5.7 ± 6.8 2.3 0.8-26.5 
MCEPP 22.5 ± 32.0 8.8 2.3-132 
MHiNP 22.9 ± 31.1 11.1 1.3-114 
MOiNP 4.7 ± 8.4 1.5 0.1-27.2 
MCiOP 56.3 ± 96.7 14.1 1.0-332 
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As seen in Table 4, the metabolite concentrations were generally higher in the group with 
plastic flooring, although not significantly so for all metabolites. Figure 1 demonstrates this 
with box plots, showing the two groups next to each other. MBzP is the metabolite found in 
highest concentrations.  
 
 
Table 4. Phthalate metabolite concentrations after correction for urine density, values in ng/ml 
 All dogs (n=15)  Plastic flooring (n=7)  Non-plastic flooring (n=8) 
 
Mean ± 
stdva 
Media
n Range  Mean ± stdv Median  Mean ± stdv Median 
 P-
valueb 
MEP 24.5 ±18.4 17.5 4.4-58.2  24.2 ± 19.5 23.6  24.7 ± 18.7 15.1  0.39 
MnBP 60.7 ± 41.2 48.1 19.3-155  79.5 ± 49.2 82.9  44.3 ± 25.5 35.0  0.08 
MBzP 72.6 ± 134 17.6 2.6-506  144 ± 175 105  9.8 ± 7.4 6.7  0.005 
MEHP 20.1 ± 20.5 6.3 1.3-58.0  31.9 ± 22.0 34.8  9.7 ± 12.7 5.3  0.03 
MHEHP 63.6 ± 71.9 31.6 8.3-276  101 ± 91.2 94.5  30.8 ± 23.8 23.5  0.03 
MOEHP 5.3 ± 5.0 3.2 0.7-16.0  7.9 ± 5.7 6.9  3.0 ± 3.0 1.7  0.05 
MCEPP 21.8 ± 24.0 12.8 2.0-93.8  36.1 ± 28.1 25.3  9.2 ± 9.5 5.4  0.005 
MHiNP 25.2 ± 33.9 7.2 2.8-117  25.7 ± 29.8 8.9  24.7 ± 39.1 6.7  0.39 
MOiNP 5.3 ± 8.2 1.2 0.2-25.3  6.1 ± 8.4 1.4  4.6 ± 8.5 0.9  0.31 
MCiOP 60.8 ± 96.0 10.0 2.7-342  62.1 ± 75.0 10.7  59.6 ± 116 9.3  0.35 
 aStandard deviation. 
bOne-sided Wilcoxon two-sample exact test for differences between flooring groups. P-values <0.05 are considered 
significant. 
 
 
 
 
Figure 1. Urine concentrations of the ten phthalate metabolites corrected for urine density, values in 
ng/ml (blue = group with plastic flooring, pink = group with non-plastic flooring). 
0,0
100,0
200,0
300,0
400,0
500,0
600,0
n
g/
m
l
MEP      MnBP       MBzP       MEHP       MHEHP     MOEHP     MCEPP      MHiNP     MOiNP      MCiOP
Blue = Group with plastic flooring
Pink = Group with non-plastic flooring
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Five of the ten metabolites were found in significantly higher levels in the group of dogs with 
plastic flooring, compared to the group of dogs with non-plastic flooring (p<0.05, Table 4). 
These were the metabolites of the phthalates BBzP (MBzP) and DEHP (MEHP, MHEHP, 
MOEHP, MCEPP). For the metabolites of DEP, DBP and DiNP the difference between the 
groups was not significant. Figures 2, 3, 4, 5 and 6 show the metabolites where a statistically 
significant difference (p<0.05) was found between the two groups.  
 
 
Figure 2. Urine concentrations of MBzP, metabolite of the phthalate BBzP, corrected for urine 
density.  
 
 
Figure 3. Urine concentrations of MEHP, metabolite of the phthalate DEHP, corrected for urine 
density.  
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Figure 4. Urine concentrations of MHEHP, metabolite of the phthalate DEHP, corrected for urine 
density.  
 
 
Figure 5. Urine concentrations of MOEHP, metabolite of the phthalate DEHP, corrected for urine 
density.  
 
 
Figure 6. Urine concentrations of MCEPP, metabolite of the phthalate DEHP, corrected for urine 
density. 
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There were significant differences in urine concentrations of the metabolites MEP (metabolite 
of DEP), MBzP (metabolite of BBzP) and MHEHP (metabolite of DEHP) between dogs 
using plastic toys and dogs not using plastic toys (p=0.01, p=0.01 and p=0.02, respectively). 
Higher urine concentrations were found in the group of dogs using plastic toys. For MEP, the 
median values of the corrected urine concentrations were 43.7 ng/ml for dogs using plastic 
toys, and 12.3 ng/ml in the group not using plastic toys. The corresponding medians for 
MBzP were 94.2 and 10.3 ng/ml, respectively. For MHEHP, the median in the group using 
plastic toys was 72.6 ng/ml and 18.2 ng/ml in the group not using plastic toys.  
 
DISCUSSION 
This study consists of a small sample of dogs, which has to be considered when looking at the 
results. The main aim was to quantify phthalate concentrations in urine from dogs, and to 
investigate differences in urine metabolite concentrations due to differences in the dogs’ home 
environments, primarily plastic flooring compared to non-plastic flooring. The dogs 
participating in the study were selected to achieve an even distribution of sexes and a 
relatively similar weight in the two groups, to make the two groups as comparable as possible. 
The results also showed that there was no difference in body weight or age between the group 
with plastic flooring and the group with non-plastic flooring. The time of day for which the 
urine sample was collected varied between the dogs and there was a variation in how many 
hours had passed since the dog had last been taken out for a walk (at least 2 hours). To 
compensate for this the metabolite concentrations were corrected for urine density.  
 
All dogs included in the study had measurable levels of each of the ten phthalate metabolites, 
which leads to the conclusion that dogs are exposed to and absorb phthalates from the 
environment. The results showed that the concentrations were generally higher for all 
metabolites in the group with plastic flooring, compared to the group with non-plastic 
flooring. This difference between the groups was statistically significant (p<0.05) for five of 
the ten metabolites. These were the metabolite of the phthalate BBzP and the four metabolites 
derived from DEHP. This suggests that dogs living in homes with plastic flooring are at risk 
of being exposed to a larger amount of phthalates, compared to dogs living in homes without 
plastic flooring. These results correspond well to a study carried out by Carlstedt et al. (2013), 
where the urine concentration of MBzP (metabolite of BBzP) measured in children was 
significantly higher in infants exposed to PVC flooring compared to infants not exposed to 
PVC flooring. Carlstedt et al. (2013) conclude that their results indicate that PVC flooring is 
an important source for human uptake of BBzP. Similarly, the results in this study indicate 
that plastic flooring is an important source also for canine uptake of BBzP. Flooring is one of 
two products in Sweden and Denmark where the highest levels of BBzP can be found (KemI, 
2014), which could explain why the metabolite MBzP is one of the metabolites where a 
significant difference was found between the two groups. 
 
In this study, the results showed a significant difference between dogs using plastic toys and 
dogs not using plastic toys for urine concentrations of the metabolites MEP, MBzP and 
MHEHP. Other studies have previously identified the parent compounds for these metabolites 
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in canine toys, for example DEHP (Nohrborg, 2015; Wooten & Smith, 2013) of which 
MHEHP is a metabolite, and BBzP and DEP (Wooten & Smith, 2013) of which MBzP and 
MEP are metabolites. One of the studies also showed estrogenic and anti-androgenic activity 
of some of the phthalates found in dog toys in in vitro assays (Wooten & Smith, 2013). These 
results indicate that plastic toys could possibly have an influence on urine metabolite 
concentrations of phthalates in addition to plastic flooring, and should be considered as a 
source of exposure to phthalates for dogs. However, this study was primarily designed to find 
differences between dogs living in homes with plastic flooring and dogs living in homes 
without plastic flooring. Because of this, the sample sizes when testing the effect of plastic 
toys were unbalanced. Some of the dogs with plastic toys also lived in homes with plastic 
flooring, which could affect the results. Future studies should take the use of plastic toys into 
account as a risk factor when studying phthalate metabolite concentrations in dog urine.  
 
Because dogs are kept as companion animals living in the same environment as their owners, 
dogs could possibly be used as an indicator for human exposure to phthalates. Studying the 
urine excretion of phthalate metabolites in dogs may offer a non-invasive and practical tool 
for assessing the level of phthalate exposure that humans are subjected to in their home 
environment. Latini (2005) states that frequent monitoring of human phthalate metabolite 
concentrations in body fluids such as urine would be “highly advisable” as a tool for health 
risk assessment, and as a guide when establishing regulations for the use of phthalates. It is 
possible that measuring phthalate metabolite concentrations in dog urine could be a helpful 
part in this.   
 
It is of interest to determine if the levels of urinary metabolites found in this study correspond 
to levels found in human urine samples. However, comparisons are complicated by the fact 
that the type of urine samples used differs (spot urine sample, morning urine sample or 24 
hour urine sample) and that it varies if the metabolite concentrations have been corrected for 
urine density. Carlstedt et al. (2013) studied the concentration of phthalate metabolites in spot 
urine samples from 83 Swedish children (2-6 months old) of which 35 % had PVC flooring in 
the infant’s bedroom. The uncorrected median value for urine concentrations of MBzP (for all 
children participating in the study, PVC flooring or other) was 10.5 ng/ml in the study by 
Carlstedt et al. (2013), whereas the uncorrected median for all dogs in our study was 12.0 
ng/ml. For MEP the uncorrected median was 19.6 ng/ml (Carlsted et al., 2013) and in our 
study 14.6 ng/ml. For MnBP the uncorrected median was 39.1 ng/ml (Carlstedt et al., 2013) 
and in our study 37.6 ng/ml. In summary, the median concentrations for the metabolites 
MBzP, MEP and MnBP in this study are similar to the median concentrations found in 
Swedish children (Carlstedt et al., 2013).   
 
In a different study, Frederiksen et al. (2011) analysed the urine levels of phthalate 
metabolites in Danish children and adolescents aged 6-21 years. In that study, the uncorrected 
median concentrations of MBzP was 17 ng/ml in the 24 hour urine sample and 32 ng/ml in 
the morning urine sample, compared to the uncorrected median in this study which was 12.0 
ng/ml and the corrected median of 17.6 ng/ml. Yet another study by Boas et al. (2010) on 
phthalate metabolites in spot urine samples from 845 Danish children (ages 4-9 years) show 
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concentrations in about the same region for several metabolites of DEP, BBzP and DEHP. For 
example, the median concentration of MEP in the study by Boas et al. (2010) was 21 ng/ml, 
in our study the uncorrected median for all dogs was 14.6 ng/ml and the corrected median 
17.5 ng/ml. The concentrations in the studies by Carlstedt et al. (2013), Frederiksen et al. 
(2011) and Boas et al. (2010) have not been corrected for urine density like the concentrations 
in this study. If they had been corrected for urine density a more accurate comparison could 
have been made with our corrected values. Still, the uncorrected values are in about the same 
interval in several cases. This suggests that the level of exposure to phthalates might be 
similar for dogs and young children.  
 
In the study by Frederiksen et al. (2011) the concentrations of phthalate metabolites in the 24 
hour urine sample were used to estimate a daily phthalate intake. The estimated daily intake 
was then compared to the Tolerable Daily Intake (TDI) of four phthalates. The TDIs for 
phthalates have been set by the Scientific Committee of Food (SCF) and evaluated by the 
European Food Safety Authority (EFSA) in 2005 (EFSA 2005a, 2005b, 2005c, 2005d). The 
TDI for DEHP is set to 0.05 mg per kg body weight per day and the TDIs for BBzP, DBP and 
DiNP are 0.5, 0.01 and 0.15 mg per kg body weight per day, respectively. Frederiksen et al. 
(2011) found that the estimated daily intakes of the two isoforms of DBP exceeded the TDI in 
several of the children. In one child the TDI for DEHP was exceeded. A second study that 
estimated the daily intake of DEHP in German children found that TDI was exceeded in three 
children (1%) (Wittassek et al., 2007). Similar studies could be performed on dogs to 
calculate an estimated daily phthalate intake. Assuming a similar TDI for dogs as humans, it 
could be speculated that some dogs might exceed the recommended daily intake of phthalates 
for some of the metabolites, seeing as the concentrations found in this study in dogs are in the 
same interval as concentrations found in humans, however more studies are needed.   
 
If this level of exposure to phthalates affects the health of dogs is still unclear. It is known that 
phthalates have adverse effects on the male and female reproductive system in primarily 
rodents. There are also a few studies carried out on dogs, such as the in vitro study on 
testicular cells from dogs by Pathirana et al. (2011) showing effects of MBP and MEHP on 
the secretion of testosterone. The concentrations of phthalates used in these experimental 
studies are generally much higher than TDI-levels. For example, effects are shown in studies 
after maternal exposure during gestation by oral gavage to 750 mg/kg/day of DEHP (Parks et 
al., 2000; Gray et al., 2000), BBzP and DiNP (Gray et al., 2000). Stroheker et al. (2005) 
showed effects starting from a dose of 100 mg DEHP/kg bw/day. However, phthalates may 
possibly be more toxic or have different mechanisms at lower doses because of their non-
monotonic dose response (Beausoleil et al., 2013; Hannon & Flaws, 2015). Therefore, further 
studies on the effects of long-term exposure to lower concentrations that correlate to 
concentrations found in samples from normal humans or dogs would be of interest.  
 
CONCLUSION 
In summary, this study has shown measurable levels of ten different phthalate metabolites in 
urine samples from sixteen pet dogs. The metabolite of BBzP (MBzP) was found in the 
17 
 
highest concentrations. The metabolites of BBzP and DEHP were found in significantly 
higher concentrations in the group of dogs living in homes with plastic flooring, compared to 
dogs living in homes without plastic flooring, which suggests that exposure to a home 
environment with plastic flooring leads to higher phthalate metabolite concentrations in urine. 
The study also identified plastic toys as a possible risk factor for having higher phthalate 
metabolite concentrations. Since dogs living in homes with plastic flooring had significantly 
higher concentrations of some of the metabolites that are commonly used in PVC-flooring, it 
suggests that dogs could possibly be used as indicators for indoor environments. The 
concentrations found in this study are in around the same range as concentrations found in 
urine samples from humans. More studies are needed in order to investigate if this exposure to 
phthalates has a negative effect on the reproductive health and fertility of dogs.  
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